Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib

Fig. 3

Estimated relationships between PASDAS and EQ-5D-3L VAS (a) and EQ-5D-3L UI (b). Data from OPAL Broaden (N = 422) and OPAL Beyond (N = 394); all treatment groups from each phase 3 study were pooled for analysis. Arrows indicate the direction of improvement. EQ-5D-3L, EuroQoL-Five Dimensions-Three Level Health Questionnaire; PASDAS, Psoriatic Arthritis Disease Activity Score; UI, utility index; VAS, visual analog scale

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us